| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 92701 |
CAS:112193-75-6 DO-(CH2COOH)2 |
152 |
zyl |
2024-11-22 |
| 92702 |
DOTA-ss T2-ANT DOTA偶联SSTR2肽拮抗序列 |
144 |
zcy |
2024-11-22 |
| 92703 |
TA-DOTA-GA |
332 |
kx |
2024-11-22 |
| 92704 |
DOTA-(D-Gln)2-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2 |
137 |
wyh |
2024-11-22 |
| 92705 |
CAS:321835-55-6 RGO812Q0C8 |
189 |
zyl |
2024-11-22 |
| 92706 |
CAS:1027785-95-0 Ga-DOTA-NOC |
119 |
zyl |
2024-11-22 |
| 92707 |
苯乙炔基苯酐(PEPA)119389-05-8 |
157 |
WYQ |
2024-11-22 |
| 92708 |
NCS-MP-NODA;1374994-81-6 |
193 |
wyh |
2024-11-22 |
| 92709 |
Lu-DOTA-sst2-ANT Lu金属偶联双功能螯合剂DOTA-sst2-ANT |
150 |
zcy |
2024-11-22 |
| 92710 |
polylysine-(Gd-DOTA) |
154 |
zyl |
2024-11-22 |
| 92711 |
二甲基二氯硅烷,75-78-5,C2H6Cl2Si |
177 |
WYQ |
2024-11-22 |
| 92712 |
DOTA-五聚乙二醇-叠氮 |
139 |
kx |
2024-11-22 |
| 92713 |
DOTA-Glu-[cyclo(Arg-Gly-Asp-D-Phe-Lys(Acp))]2 |
131 |
wyh |
2024-11-22 |
| 92714 |
Etelcalcetide-DOTA |
145 |
kx |
2024-11-22 |
| 92715 |
DOTA-Arg-Gly-Asp-Ser-Pro-Lys-OH |
149 |
wyh |
2024-11-22 |
| 92716 |
CAS:437608-50-9 Lutathera |
151 |
zyl |
2024-11-22 |
| 92717 |
Ga-DOTA-WVP Ga-DOTA偶联的WVP肽 双功能螯合剂DOTA修饰WVP肽 |
171 |
zcy |
2024-11-22 |
| 92718 |
CAS:2057438-24-9 Dotatate tfa |
159 |
zyl |
2024-11-22 |
| 92719 |
DOTA-tris(TBE)-amido-dPEG24-TFP ester |
124 |
kx |
2024-11-22 |
| 92720 |
N-(4-乙炔基苯甲酰基)-L-环己基甘氨酸乙酯(PAA-Chg) |
132 |
WYQ |
2024-11-22 |
| 92721 |
DOTA-iRGD peptide ;DOTA偶联iRGD peptide |
145 |
wyh |
2024-11-22 |
| 92722 |
CAS:306776-79-4 DOTAGA-tetra (t-Bu ester) |
117 |
zyl |
2024-11-22 |
| 92723 |
N-丙基-2-炔基邻苯二甲酰亚胺,N-Propyl-2-ethynylphthalimide |
165 |
WYQ |
2024-11-22 |
| 92724 |
3-羟基-4-((三甲基甲硅烷基)乙炔基)苯甲酸甲酯 |
159 |
WYQ |
2024-11-22 |
| 92725 |
4-苯乙炔基-4'-二甲氨基查尔酮 |
133 |
WYQ |
2024-11-22 |
| 92726 |
DOTA-RGD的结构特点 |
154 |
wyh |
2024-11-22 |
| 92727 |
CAS:872469-60-8 大环化合物 |
129 |
zyl |
2024-11-22 |
| 92728 |
CAS:1006711-90-5,Maleimide-DOTA,DOTA-马来酰亚胺 |
147 |
kx |
2024-11-22 |
| 92729 |
1-芳乙炔基-3-芳甲酰基中氮茚,1-Aryl Ethynyl-3-Arylcarbonylindole |
153 |
WYQ |
2024-11-22 |
| 92730 |
3-羟基-4-((三甲基甲硅烷基)乙炔基)苯甲酸甲酯 |
147 |
WYQ |
2024-11-22 |
| 92731 |
CAS:157599-02-5 1,4,7,10-四(氨基羰甲基)-1,4,7,10-四氮杂环十二烷 |
139 |
zyl |
2024-11-22 |
| 92732 |
DOTA-peptides DOTA-多肽 |
120 |
zcy |
2024-11-22 |
| 92733 |
丁炔基磷杂环戊烷(BYP) |
209 |
WYQ |
2024-11-22 |
| 92734 |
DOTA-pVEC; DOTA偶联细胞穿膜肽pVEC |
137 |
wyh |
2024-11-22 |
| 92735 |
2,5-双{β-[p-(6-羟基己氧基)苯基]乙炔基}嘧啶 |
149 |
WYQ |
2024-11-22 |
| 92736 |
DOTA-DBCO |
122 |
kx |
2024-11-22 |
| 92737 |
CAS:913542-71-9 DOTA di(tBu)ester |
136 |
zyl |
2024-11-22 |
| 92738 |
2-(4-羟基-1-丁炔基)苯腈 |
127 |
WYQ |
2024-11-22 |
| 92739 |
苯乙炔基硅氧硼烷(PESB) |
231 |
WYQ |
2024-11-22 |
| 92740 |
DOTA-YTA2 ; DOTA偶联细胞穿膜肽YTA2 |
130 |
wyh |
2024-11-22 |
| 92741 |
DOPE-PEG-DOTA 磷脂-聚乙二醇-大环配体 |
161 |
zyl |
2024-11-22 |
| 92742 |
N-[4-[1-(2,4-二氨基-6-蝶啶)甲基-3-丁炔基]苯甲酰]-L-谷氨酸烷基酯 |
194 |
WYQ |
2024-11-22 |
| 92743 |
DOTA-tris(TBE)-amido-dPEG4-TFP ester |
156 |
kx |
2024-11-22 |
| 92744 |
1,3,5-三[3-(三甲基硅乙炔基)-5-(三异丙基硅乙炔基)苯基乙炔基]苯(B2) |
142 |
WYQ |
2024-11-22 |
| 92745 |
CAS:177943-88-3 DOTATATE |
145 |
zyl |
2024-11-22 |